Allergy and Asthma Proceedings

Papers
(The median citation count of Allergy and Asthma Proceedings is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
For the Patient78
Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination72
SARS-CoV-2 infection and the human immune system: A continuing journey of discovery43
Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist32
Impact of steroids on the immune profiles of children with asthma living in the inner-city29
The role of leukocyte activation in suspected Non-IgE excipient-related COVID-19 vaccine reactions: An exploratory hypothesis-driven study of pathogenesis25
Molecular allergy diagnostics in predicting oral cow's milk challenge outcome in Finnish children23
Association of exposure to ambient particulate matter with asthma in children: Systematic review and meta-analysis23
Venom allergen immunotherapy21
Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being19
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A post-hoc analysis of RELIght study19
Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks19
Future directions in allergen immunotherapy19
Operationalizing shared decision making in clinical practice19
TEV/FEV3 as a coherent metric of small airway dysfunction in childhood asthma18
Abstracts presented at the Western Society of Allergy, Asthma & Immunology, Annual Scientific Session, February 6-10, 2022, Maui, Hawaii18
For the Patient18
For the Patient17
Demographics and characteristics of leadership at allergy and immunology fellowships in the U.S. as of 202217
Quality of life in primary immunodeficiency: Its contribution to shared decision-making and patient outcomes17
Evaluation and management of chronic cough in adults16
Assessment of pediatric patients with suspected nonsteroidal anti-inflammatory drug hypersensitivity16
Clinical effects of intranasal corticosteroids on nasal symptoms in subjects with chronic rhinitis during COVID-1915
Treatment strategies for postviral olfactory dysfunction: A systematic review15
For the Patient15
Association between air pollution and the prevalence of allergic rhinitis in Chinese children: A systematic review and meta-analysis14
Epinephrine autoinjector prescribing following anaphylaxis presentation to the emergency department13
A 33-year-old man with a history of recurrent pneumonia presenting with hypoxemic respiratory failure13
Comparison of commercial allergen extract with various milk products of skin prick tests in diagnosing cow's milk protein allergy13
Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course13
The safety of initial single therapeutic dose challenge with a 5-day prolonged drug provocation test in children with a history of low-risk non-immediate reactions to beta-lactam antibiotics12
Systematic review of omalizumab for refractory clonal and non-clonal mast cell activation syndrome12
For the Patient12
For the Patient11
Unraveling allergic, pseudoallergic, and idiosyncratic complexities of hypersensitivity reactions to NSAIDs11
Diagnostic utility of basophil CD203c expression in β-lactam allergy11
Navigating the management complexity in long-term asymptomatic immunodeficiency11
Effects of mechanical washing and drying on the removal of pet allergens10
Abstracts Presented at the Western Society of Allergy, Asthma & Immunology, February 4‐8, 2024, Koloa, Hawaii10
Can depression and anxiety be predicted in hereditary angioedema? A comprehensive assessment10
For the patient10
Oral food challenge to milk is still necessary to diagnose cow's milk allergy and should be conducted in adequate facilities10
A tribute to allergy and immunology fellowship training program directors and to the fellows they train10
A case of a rash after tetanus-diphtheria-pertussis and meningococcal vaccination10
Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy9
Diagnostic value of YKL-40 for patients with asthma: A meta-analysis9
From burden to breakthrough: Advances in hereditary angioedema, drug allergy, and allergic disease prevention9
Eosinophilic granulomatosis with polyangiitis in allergic asthma: Efforts to make early diagnosis possible9
Real-world effectiveness of dupilumab versus benralizumab and mepolizumab9
Guidelines for management of hereditary angioedema: What is new? What is missing?9
Paucigranulocytic asthma: Do sputum macrophages matter?8
Metal implant allergy: A retrospective cohort analysis at a university allergy practice8
Primary Immunodeficiency: Specific antibody deficiency with normal IgG8
Treatment options for chronic rhinosinusitis with nasal polyps8
Effect of COVID-19 on hereditary angioedema activity and quality of life8
Hematopoietic stem cell transplantation for primary immunodeficiency8
Vaccine preventable diseases, vaccine hesitancy, and COVID-19: A role for the allergist/immunologist8
Presented at the Western Society of Allergy, Asthma & Immunology, February 5‐9, 2023, Kamuela, Hawaii8
Clinical features of anaphylaxis in children8
Evaluation of atopic diseases in patients with allergic contact dermatitis8
Prophylactic therapy with subcutaneous C1-inhibitor is associated with sustained symptom control in patients with hereditary angioedema8
Benralizumab in the management of rare primary eosinophilic lung diseases8
Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study8
Efficacy of anti-interleukin 5 therapy in hypereosinophilic syndrome: An updated systematic review and meta-analysis7
Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-27
Overview of secondary immunodeficiency7
Shared decision-making in the management of hereditary angioedema: An analysis of patient and physician perspectives7
Early clinical improvement of anosmia and sinus nitric oxide in chronic rhinosinusitis with nasal polyps subjects treated with dupilumab7
Food-induced anaphylaxis in early childhood and factors associated with its severity7
Abstracts published from the New England Society of Allergy Annual Fall Meeting, October 22‐23, 2022, Portsmouth, NH7
Curcumin does not significantly affect immediate skin tests7
The long COVID syndrome: A conundrum for the allergist/immunologist7
The association of timothy grass allergy and cat ownership on cat sensitization7
Adding tiotropium or long-acting β2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization7
Birch-naive, oak-allergic subjects' response to birch pollen in an environmental chamber7
For the Patient7
Impact of penicillin allergy labels among pneumonia admissions at an academic children's center7
Cost-effectiveness of school integrated pest management and air filtration in students with asthma7
Safety of ciclesonide in children with asthma: A review of randomized controlled trials7
Caregiver perceptions and attitudes associated with oral immunotherapy on social media7
Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy7
The long-term outcomes of mepolizumab treatment at 100 mg dose on idiopathic chronic eosinophilic pneumonia: A real-life experience6
Abstracts presented at the Eastern Allergy Conference, June 3‐6, 2021, Palm Beach, Florida6
Assessing cross-reactivity in allergen immunotherapy6
A masquerade of recurrent anaphylaxis6
Markers of eosinophilic airway inflammation in patients with asthma and allergic rhinitis6
Diagnosis of eosinophilic esophagitis in patients with dysphagia during the Coronavirus Disease 2019 (COVID-19) pandemic6
Real-world effectiveness and predictors of super-responders to dupilumab in a Chinese uncontrolled asthma cohort6
Evaluation of allergic diseases in children diagnosed with cutaneous mastocytosis6
Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study6
Efficacy of parenteral bronchodilators on ventilatory outcomes in pediatric critical asthma: a national cohort study6
2-Octyl cyanoacrylate, a hidden allergen, a common cause of postsurgical allergic contact dermatitis6
Essentials of an immunodeficiency primer: A practical reference for the allergist/immunologist and the allergy-immunology fellow-in-training (FIT)6
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan6
How important is proper dosing for subcutaneous and sublingual allergy immunotherapy?6
Blended problem based learning in postgraduate education: The Eastern Allergy Conference and the PBL Institute experience5
A comparative study of chronic spontaneous urticaria and chronic mast cell mediated angioedema5
The COVID-19 impact on severe uncontrolled asthma costs and biologic use5
Abstracts presented at the Eastern Allergy Conference, June 2‐5, 2022, Palm Beach, Florida5
Clinical and economic burden of chronic rhinosinusitis with nasal polyposis: A U.S. administrative claims analysis5
Peanut allergy in an adult following cardiac transplant from a non-atopic donor5
Efficacy and safety of Janus kinase selective inhibitors in the treatment of atopic dermatitis: A systematic review and meta-analysis5
Influence of aeroallergen sensitization and nasal polyposis on mepolizumab response in eosinophilic severe asthma5
A confluence of advanced treatment options for atopic dermatitis, eosinophilic lung diseases and chronic urticaria brought about by the revolutionary discovery of biologics and Janus kinase inhibitors5
Mechanisms and biomarkers of subcutaneous immunotherapy and sublingual immunotherapy in allergen immunotherapy5
Genetically-determined defects of T cell development5
Immunodeficiency: Burden of Illness5
Delayed systemic urticarial reactions following mRNA COVID-19 vaccination5
The immunologic response to severe acute respiratory syndrome coronavirus 25
Interleukin-33, endothelin-1, and inflammatory parameters in chronic spontaneous urticaria5
Early testing and grade of the reaction are affecting factors of skin test positivity in β-Lactam allergies5
Evaluation of disease control after SARS-CoV-2 infection or vaccination in patients with NSAID-exacerbated airway disease5
For the patient5
COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications5
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan5
Treatment options for moderate to severe atopic dermatitis4
Does aeroallergen sensitivity and allergic rhinitis in children cause milder COVID-19 infection?4
Salivary and serum IgA and IgG after COVID-19 and after immunization with COVID-19 vaccines4
A review of allergen immunotherapy in asthma4
Idiopathic anaphylaxis: Diagnosis and management4
The diagnostic accuracy of spirometry versus peak expiratory flow test for follow-up of adult asthma patients at primary care level4
For the patient4
Initial characteristics and follow-up of patients with a diagnosis of angiotensin-converting enzyme inhibitor induced angioedema4
Cat allergy in children and the effect of the COVID-19 pandemic4
Anaphylaxis: Long-term management and resources4
Factors influencing the quality of life in children with atopic dermatitis in Korea: A multicenter cross-sectional study4
Immunoglobulin replacement for primary immunodeficiency: Indications for initiating and continuing treatment4
For the Patient4
COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol4
Persistent airflow obstruction in inner-city children with asthma4
Studies of methylated CpG ODN from Bifidobacterium longum subsp. infantis in a murine model: Implications for treatment of human allergic disease4
Effect of prenatal phthalate exposure on childhood atopic dermatitis: A systematic review and meta-analysis4
Successful rapid liposomal amphotericin B desensitization in pediatric case series4
Clinical implications of asthma endotypes and phenotypes4
Peptide immunotherapy for aeroallergens4
Integrating innovation and shared decision-making in allergy and immunology practice4
Removing penicillin allergy label in a hospitalized adolescent with a remote penicillin and recent cephalosporin allergy4
Allergy immunotherapy for allergic fungal respiratory diseases3
Exploring mast cell disorders: Tryptases, hereditary alpha-tryptasemia, and MCAS treatment approaches3
Assessment of mask use on oxygen saturation in adults and children with asthma3
A systematic review and meta-analysis exploring the bidirectional association between asthma and gastroesophageal reflux disease in children3
The effect of the socioeconomic status on the measurement of asthma control3
The complexities of allergic diseases continue to challenge the allergist-immunologist3
Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose3
Accelerated/rush allergen immunotherapy3
Persistent urticarial rash in a newborn3
Selective immunoglobulin E deficiency and its association with autoimmune and autoinflammatory diseases3
Impact of type 2 targeting biologics on acute exacerbations of chronic rhinosinusitis3
Management and referral patterns for new-onset chronic cough in primary care patients3
Current concepts in optimized construction of allergen immunotherapy vaccines: Practical implications3
Atopic dermatitis: Best of guidelines and yardstick3
Allergic comorbidities in fibromyalgia3
Capturing total steroid burden in patients with atopic dermatitis and asthma3
Addressing global health disparities in the management of RSV infection in infants and children: Strategies for preventing bronchiolitis and post-bronchiolitis recurrent wheezing3
Oral immunotherapy with sunflower seed butter and a review of seed allergy3
Common but neglected problem in chronic spontaneous urticaria: Sleep disturbance3
The utility of shared decision making in the management of hereditary angioedema3
Dose-dependent association between inhaled corticosteroid use and risk of obesity and metabolic syndrome in asthma3
Evaluation of direct oral provocation test results in mild cutaneous reactions to cephalosporins in children3
Prevalence and bidirectional association between rhinitis and urticaria: A systematic review and meta-analysis3
Health disparities investigated in a primary care penicillin allergy removal pathway3
For the patient3
United States Pharmacopeia guidance for compounding of allergenic extracts for allergen immunotherapy3
The third pandemic: The respiratory syncytial virus landscape and specific considerations for the allergist/immunologist3
Chronic cough in asthma is associated with increased airway inflammation, more comorbidities, and worse clinical outcomes3
Association of EDN levels in patients with asthma and correlation with FEV1%: A meta-analysis2
The relationship between childhood atopic dermatitis and asthma in an under resourced community2
Navigating the uncharted waters of chronic urticaria: A perplexing challenge for the allergist-immunologist2
For the Patient2
Eosinophil-derived neurotoxin: An asthma exacerbation biomarker in children2
SNOT-22 scores after 6 months of aspirin therapy are predictive of long-term quality of life in AERD2
Berotralstat (BCX7353) is a novel oral prophylactic treatment for hereditary angioedema: Review of phase II and III studies2
Fruit allergy and anaphylaxis in children: Culprit fruits and clinical findings2
Evaluation of different protocols for classification of pediatric hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: Children with underlying allergic disease should be a separate sub2
Becoming attack-free further improves health-related quality of life in patients with hereditary angioedema receiving garadacimab2
Risk factors predisposing children to transient hypogammaglobulinemia of infancy2
Early-life risk factors for recurrent wheezing in preschool children: A meta-analysis of 15 cohort studies2
To test or not to test: Lessons learned from screening infants for peanut allergy2
Health-related quality of life in children with hereditary angioedema compared with patients with histaminergic angioedema2
Angioedema without urticaria: Diagnosis and management2
Symptom flares after COVID-19 infection versus vaccination among youth with PANS/PANDAS2
Evaluation and management of adverse reactions to the COVID-2019 vaccines2
Current and emerging therapies for eosinophilic esophagitis2
Relationship between autoimmune diseases and serum basal immunoglobulin E levels in patients with common variable immunodeficiency2
The need for continuous quality assessment for providing optimal comprehensive care for patients with alpha-1 antitrypsin deficiency2
Prognosis of food-induced anaphylaxis in children: A single-center real-life study2
Review of efficacy of ciclesonide for the treatment of asthma in children2
Efficacy and safety of crisaborole in patients with mild-to-moderate atopic dermatitis and other atopic comorbidities2
Evaluation of sinonasal involvement in patients with asthma and chronic obstructive pulmonary disease2
Dose-response studies of methylated and nonmethylated CpG ODNs from Bifidobacterium longum subsp. infantis for optimizing Treg cell stimulation2
Interaction between asthma and overweight/obesity on cancer results from the National Health and Nutrition Examination Survey 2005‐20182
Physician- and patient-reported outcomes by hereditary angioedema type: Data from a real-world study2
Pediatric sublingual allergen immunotherapy2
Do commercial dog extracts cross-react with Felis domesticus allergen 12
COVID-19: A continuing challenge for the allergist/immunologist2
Outcomes among patients with COVID-19 and asthma: A systematic review and meta-analysis2
Female sex as a risk factor for penicillin drug allergy in the inpatient setting2
Allergic diseases in children: A continuing challenge for the Allergist-Immunologist2
Appraisal of the evidence linking hereditary α-tryptasemia with mast cell disorders, hypermobility and dysautonomia2
Idiopathic non-mast cell angioedema: Treatment insights from global experts2
Clinical characteristics of cat sensitized adults, cat ownership and cat owners' attitudes2
The challenge of neurologic disease for the allergist/immunologist2
Diagnosis of ciprofloxacin hypersensitivity improves by incorporating MRGPRX2 in basophil activation test2
Hymenoptera venom immunotherapy: Safety and efficacy of an accelerated induction regimen with depot aluminum adsorbed extracts2
Subcutaneous allergen immunotherapy in the treatment of allergic respiratory disease2
Abstracts presented at the Eastern Allergy Conference May 30‐June 2, 2024, Palm Beach, Florida2
Effect of bariatric surgery on lung function and asthma control after 8 years of follow-up2
Health disparities in hymenoptera venom allergy management2
Single-bag rapid drug desensitization for chemotherapeutic hypersensitivity reactions: A single-center experience2
From diagnosis to desensitization in immediate hypersensitivity reactions to both oral and parenteral iron salts2
1.1913990974426